Mortgage Market Activity: The podcast discusses a significant surge in mortgage refinancing and new loan activity due to a drop in average mortgage rates to 6.49%, with refinancing activity up 34% year-over-year, indicating a potential thaw in the housing market.
Oracle's Earnings Report: Oracle's stock saw a dramatic increase of 40% following a strong earnings report, highlighted by a 359% growth in remaining performance obligations, suggesting robust future demand, although concerns about the costs associated with infrastructure growth were also raised.
ETF Milestone: The podcast notes that exchange-traded funds (ETFs) have surpassed the number of individual stocks listed on exchanges, reflecting a shift in investor preference towards lower-cost investment options, with discussions on the implications of this trend.
Investment Insights: Contributors share their stock picks influenced by current market conditions, with mentions of Rocket Companies and Upstart as potential beneficiaries of the housing market recovery, and discussions on ETFs like the Defiance Quantum ETF and Vanguard Russell 2000 ETF as attractive investment opportunities.
Wall Street analysts forecast UPST stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for UPST is 56.73 USD with a low forecast of 20.00 USD and a high forecast of 80.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
13 Analyst Rating
Wall Street analysts forecast UPST stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for UPST is 56.73 USD with a low forecast of 20.00 USD and a high forecast of 80.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
7 Buy
4 Hold
2 Sell
Moderate Buy
Current: 46.090
Low
20.00
Averages
56.73
High
80.00
Current: 46.090
Low
20.00
Averages
56.73
High
80.00
Truist
Arvind Ramnani
Buy
initiated
$59
2026-01-06
Reason
Truist
Arvind Ramnani
Price Target
$59
AI Analysis
2026-01-06
initiated
Buy
Reason
Truist analyst Arvind Ramnani initiated coverage of Upstart with a Buy rating and $59 price target. From the company's inception, Upstart's core offering is anchored around GenAI, including its underwriting model, the analyst tells investors in a research note. While its model offers significant improvements to traditional credit models, it is still highly exposed to the credit cycle, and offers a levered way to play the U.S. easing rates and stable/improving consumer credit, Truist says.
Mizuho
Joseph Catanzaro
Outperform
initiated
$51
2025-12-17
Reason
Mizuho
Joseph Catanzaro
Price Target
$51
2025-12-17
initiated
Outperform
Reason
Mizuho analyst Joseph Catanzaro initiated coverage of Upstream Bio with an Outperform rating and $51 price target. The company's lead program verekitug is well positioned for a positive Phase II readout in asthma in Q1, the analyst tells investors in a research note. The firm projects $2.7B in risk-adjusted 2035 worldwide sales for verekitug and expects the positive Phase II data to drive share outperformance.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for UPST
Unlock Now
LifeSci Capital
Outperform
initiated
$43
2025-12-02
Reason
LifeSci Capital
Price Target
$43
2025-12-02
initiated
Outperform
Reason
LifeSci Capital initiated coverage of Upstream Bio with an Outperform rating and $43 price target.
Mizuho
Dan Dolev
Outperform -> Outperform
downgrade
$86 -> $66
2025-11-10
Reason
Mizuho
Dan Dolev
Price Target
$86 -> $66
2025-11-10
downgrade
Outperform -> Outperform
Reason
Mizuho analyst Dan Dolev lowered the firm's price target on Upstart to $66 from $86 and keeps an Outperform rating on the shares. The firm updated the company's model post the Q3 report.
About UPST
Upstart Holdings, Inc. is an artificial intelligence (AI) lending marketplace. The Company’s platform includes personal loans, automotive retail and refinance loans, home equity lines of credit (HELOCs), and small dollar loans. It applies artificial intelligence models and cloud applications to the process of underwriting consumer credit. Its AI marketplace connects consumers with its lending partner. Its consumers can access Upstart-powered loans via Upstart.com, through a lender-branded product on its lending partners’ own websites, and through auto dealerships that use its Upstart Auto Retail software. Its platform enables lenders provide a product their customers want, rather than letting customers seek loans from competitors. Its cloud-based software platform incorporates technologies and software development approaches to allow for development of new features, such as cloud-native technologies, data integrity and security, and configurable multi-tenant architecture, and others.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
